Happy to share 15 year follow-up of our study of rituximab Vs watchful waiting for advanced stage, asymptomatic low tumour burden FL. Substantial delay in TTNT with early rituximab makes it an excellent option for patients seeking to defer/avoid chemotherapy. #lymsm
Happy to share 15 year follow-up of our study of rituximab Vs watchful waiting for advanced stage, asymptomatic low tumour burden FL. Substantial delay in TTNT with early rituximab makes it an excellent option for patients seeking to defer/avoid chemotherapy. #lymsm
A&E is struggling but 2million attendances a month has barely increased
No one is listening!
General Practices are breaking
#GeneralPractice #MedSky
A&E is struggling but 2million attendances a month has barely increased
No one is listening!
General Practices are breaking
#GeneralPractice #MedSky